Edap Tms (EDAP) Earns Daily News Impact Rating of -0.01

Media coverage about Edap Tms (NASDAQ:EDAP) has trended somewhat negative recently, Accern reports. The research group rates the sentiment of media coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Edap Tms earned a news sentiment score of -0.01 on Accern’s scale. Accern also assigned media stories about the medical equipment provider an impact score of 45.8262341523699 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

EDAP has been the subject of a number of analyst reports. Zacks Investment Research raised Edap Tms from a “hold” rating to a “buy” rating and set a $3.50 price target for the company in a research report on Tuesday, November 28th. HC Wainwright reissued a “buy” rating and issued a $6.50 price target on shares of Edap Tms in a research report on Wednesday, November 22nd. Finally, ValuEngine raised Edap Tms from a “sell” rating to a “hold” rating in a research report on Friday, October 6th.

Shares of Edap Tms (NASDAQ EDAP) opened at $2.69 on Tuesday. The company has a market capitalization of $80.90, a price-to-earnings ratio of -33.62 and a beta of 1.02. Edap Tms has a 12-month low of $2.25 and a 12-month high of $3.85. The company has a debt-to-equity ratio of 0.11, a current ratio of 2.96 and a quick ratio of 2.35.

Edap Tms (NASDAQ:EDAP) last released its quarterly earnings results on Wednesday, November 15th. The medical equipment provider reported ($0.02) EPS for the quarter, meeting analysts’ consensus estimates of ($0.02). The business had revenue of $8.44 million during the quarter, compared to analyst estimates of $11.05 million. Edap Tms had a positive return on equity of 7.85% and a negative net margin of 5.36%. Edap Tms’s revenue was down 5.6% compared to the same quarter last year. equities analysts anticipate that Edap Tms will post -0.01 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “Edap Tms (EDAP) Earns Daily News Impact Rating of -0.01” was originally reported by Community Financial News and is the property of of Community Financial News. If you are viewing this story on another site, it was stolen and republished in violation of international copyright and trademark law. The legal version of this story can be viewed at https://www.com-unik.info/2018/01/09/edap-tms-edap-earns-daily-news-impact-rating-of-0-01.html.

About Edap Tms

EDAP TMS SA (EDAP) is a holding company engaged in developing and marketing the Ablatherm and Focal One devices. The Company operates two divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) (including lithotripsy activities). The Company is developing HIFU technology for the treatment of certain other types of tumors.

Insider Buying and Selling by Quarter for Edap Tms (NASDAQ:EDAP)

Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit